Gary S. Firestein
Directeur/Membre du Conseil chez American College of Rheumatology Research & Education Fdn
Profil
Gary S.
Firestein is the founder of Ignyta Operating, Inc. (founded in 2011).
He is currently the Director at American College of Rheumatology Research & Education Fdn.
Postes actifs de Gary S. Firestein
| Sociétés | Poste | Début |
|---|---|---|
American College of Rheumatology Research & Education Fdn
 American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | Directeur/Membre du Conseil | 17/11/2010 |
Anciens postes connus de Gary S. Firestein
| Sociétés | Poste | Fin |
|---|---|---|
Ignyta Operating, Inc.
 Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | Miscellaneous |
Ignyta Operating, Inc.
Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Health Technology |
